top of page

AUS-REISAMIC

the Australian Registry for Evaluation of Immune-related Severe Adverse Events from Monoclonal antibody Immune Checkpoint inhibitors:

 

a registry for rheumatic immune-related adverse events in Australia

A national multi-centre initiative based at Austin Health, Melbourne

in collaboration with REISAMIC

(Registre des effets indésirables sévères des anticorps monoclonaux immunomodulateurs en cancérologie),

based at Institut Gustave Roussy, Villejuif, France

©2018 by Aus-REISAMIC.

bottom of page